Terms
- Series
- 7.50% Series A Cumulative Redeemable Preferred Stock
- Liquidation Preference
- $25.00
- Coupon Rate
- 7.5%
- Rate Type
- Fixed
- Annual Dividend
- $1.88
- Payment Frequency
- Quarterly
- Cumulative
- Yes
- Perpetual
- Yes
- Convertible
- Yes
- Callable
- Yes
- First Call Date
- September 15, 2022
- First Call Price
- $25.00
- Capital Stack Ranking
- Junior To: All Debt And Other Liabilities Of The Company, Any Equity Shares Issued With Terms Specifically Providing They Rank Senior To Series A Preferred Stock (Subject To Two-Thirds Holder Approval); Pari Passu With: Any Preferred Or Convertible Preferred Stock Ranking On Parity With Series A Preferred Stock; Senior To: Common Stock, Any Class Or Series Of Equity Shares Expressly Designated As Junior To Series A Preferred Stock
- Regulatory (Basel III) Call
- Yes
- Tax Classification
- Reit Passthrough
- Qualifies for QDI
- No
- Qualifies for DRD
- No
- Shares Offered
- 2,700,000
Prospectus Summary
Global Medical REIT Inc. (NYSE: GMRE), a Maryland REIT focused on acquiring and leasing purpose-built healthcare facilities, is offering 2,700,000 shares of its 7.50% Series A Cumulative Redeemable Preferred Stock with a $25.00 liquidation preference and a fixed annual dividend of $1.875 per share ($0.46875 quarterly), payable on January 31, April 30, July 31, and October 31. The shares are perpetual with no maturity date and are callable at $25.00 on or after September 15, 2022. Critically, dividends are cumulative — meaning any unpaid dividends accrue and must be paid in full before the company can pay dividends on common stock, providing meaningful downside protection relative to non-cumulative structures. The Series A Preferred Stock ranks senior to GMRE's common stock and any junior equity, and on parity with future parity preferred shares, but is subordinate to all of the company's existing and future debt obligations. As of June 30, 2017, the company carried approximately $183 million in total debt — meaning preferred holders face structural risk if assets are insufficient to cover creditors first. The company may also redeem the preferred stock in limited circumstances to preserve its REIT qualification under charter ownership restrictions. There is no traditional bank-subsidiary structural subordination risk, but operations and cash flows flow through the Operating Partnership, so preferred dividends depend on distributions from the OP to the holding company. At the $25.00 offering price, the effective yield is 7.50% per annum. As a REIT, Global Medical REIT's dividends generally do not qualify for the preferential 15%/20% qualified dividend income (QDI) rate for individual investors or the dividends-received deduction (DRD) for corporate holders — most distributions will be taxed as ordinary income. Dividends are paid quarterly on the last day of January, April, July, and October, with record dates on the 15th of the preceding month. If the company misses six or more quarterly dividend payments (whether or not consecutive), preferred holders gain the right to elect two additional board directors — but dividends will continue to accrue and must eventually be paid before any common dividend can be resumed.
Summarized from the SEC prospectus filing.
Distribution History
| Ex-Date | Pay Date | Amount | Type |
|---|---|---|---|
| October 20, 2026 | November 13, 2026 | $0.16 | |
| September 21, 2026 | October 16, 2026 | $0.16 | |
| August 20, 2026 | September 18, 2026 | $0.16 | |
| July 20, 2026 | August 14, 2026 | $0.16 | |
| June 22, 2026 | July 17, 2026 | $0.16 | |
| May 20, 2026 | June 12, 2026 | $0.25 | |
| April 20, 2026 | May 15, 2026 | $0.25 | |
| March 20, 2026 | April 17, 2026 | $0.25 | |
| January 15, 2026 | February 2, 2026 | $0.4688 | |
| December 19, 2025 | January 9, 2026 | $0.75 | |
| September 29, 2025 | October 15, 2025 | $0.75 | |
| July 15, 2025 | July 31, 2025 | $0.4688 | |
| June 20, 2025 | July 9, 2025 | $0.75 | |
| April 15, 2025 | April 30, 2025 | $0.4688 | |
| March 21, 2025 | April 9, 2025 | $1.05 | |
| January 15, 2025 | January 31, 2025 | $0.4688 | |
| December 20, 2024 | January 8, 2025 | $1.05 | |
| October 15, 2024 | October 31, 2024 | $0.4688 | |
| September 20, 2024 | October 8, 2024 | $1.05 | |
| July 15, 2024 | July 31, 2024 | $0.4688 |
Conversion Terms
Ranking vs. Other Preferreds
- All debt and other liabilities of the Company
- Any equity shares issued with terms specifically providing they rank senior to Series A Preferred Stock (subject to two-thirds holder approval)
- Common stock
- Any class or series of equity shares expressly designated as junior to Series A Preferred Stock
- Any preferred or convertible preferred stock ranking on parity with Series A Preferred Stock
Dividend Stopper Provisions
- Any class or series of equity shares ranking senior to Series A Preferred Stock
Dividend Stopper Description
If the issuer fails to pay dividends on any shares ranking senior to the Series A Preferred Stock, it cannot pay dividends on the Series A Preferred Stock until senior arrearages are cleared; similarly, if dividends on Series A and parity preferred are not paid in full, all such dividends must be allocated pro rata.
Div Score Breakdown
Reinvesty's multi-factor safety analysis for this preferred, composite score: 31 (Weak)